P
PBYI
Puma Biotechnology Inc
7.04
-0.13-1.81%Opening15:34 06/01 EDT
OPEN/PREV CLOSE7.09/7.17
TODAY RANGE6.84-7.11
VOL160.16K
MARKET CAP358.33M
52 WEEK RANGE3.030-7.90
AVG VOL (3M)289.85K
% TURNOVER0.31%
TURNOVER--
P/E (TTM)14.76
% RANGE3.77%
EPS(TTM)0.4771
P/E(FORWARD)24.28
P/B2.789
BVPS2.524
DIVIDEND--
P/S1.554
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP303.23M
SHARES OUTSTANDING50.90M
NEXT EARNINGS08/05-08/10
FREE FLOAT43.07M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·05/20 04:13
Puma Biotechnology Lifts Outlook Despite Q1 Setback
Simply Wall St·05/15 11:52
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
Simply Wall St·05/11 13:16
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
Simply Wall St·05/09 00:55
Puma Biotechnology (PBYI) Net Margin Steady At 13.6% Challenges Bearish Earnings Narratives
TipRanks·05/09 00:20
Puma Biotechnology Raises Outlook Despite Q1 Reset
TipRanks·05/08 11:28
TD Cowen Sticks to Their Hold Rating for Puma Biotechnology (PBYI)
TipRanks·05/07 22:49
Puma Biotechnology reports Q1 adjusted EPS (4c) vs (10c) last year
TipRanks·05/07 22:48
Puma Biotechnology sees Q2 revenue $52M-$55M, one estimate $52M
TipRanks·05/07 22:47
Puma Biotechnology raises FY26 revenue view to $222M-$229M from $214M-$221M
Seeking Alpha·05/07 20:47
Puma Biotechnology Non-GAAP EPS of -$0.04 beats by $0.09, revenue of $44.8M beats by $2.8M
Benzinga·05/07 20:30
Puma Biotechnology Sees Q2 Sales $52.000M-$55.000M vs $52.000M Est